AstraZeneca shares drop 7% after report on $400 billion merger talks with Bristol Myers Squibb

Aug 3, 2026 - 04:35
 0  0
AstraZeneca shares drop 7% after report on $400 billion merger talks with Bristol Myers Squibb
The companies have discussed a potential merger over several months, the Financial Times reported on Sunday.

What's Your Reaction?

Like Like 0
Dislike Dislike 0
Love Love 0
Funny Funny 0
Angry Angry 0
Sad Sad 0
Wow Wow 0